Is aripiprazole depot/long-acting injectable (LAI) safe and effective for treating symptoms of Lewy Body Dementia (LBD) specifically?

Zenodo (CERN European Organization for Nuclear Research) 2026 Open access

Read full text
Authors: Tripdatabase
DOI: 10.5281/zenodo.19001568
Cited by: 0

Abstract

Aripiprazole LAI use in LBD-related symptoms shows small, inconsistent improvements with notable safety concerns, suggesting the need for caution in its application.

Fields of Study & Subjects

Parkinson's Disease Mechanisms and Treatments Schizophrenia research and treatment Dementia and Cognitive Impairment Research

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
13 March 2026
Language
EN